Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jan 25;22(4):10.1158/1055-9965.EPI-12-1190. doi: 10.1158/1055-9965.EPI-12-1190

Figure 2.

Figure 2

Bladder and lung cancer odds ratios* including only cases with histologic confirmation, in non-proxy subjects, and in males and females comparing subjects in the upper to lower quartiles of average lifetime arsenic concentration prior to 1971.

*Odds ratios are adjusted for age, sex, smoking, mining work, race, body-mass index, and socioeconomic status. For display purposes, the bladder cancer odds ratio in females of 23.6 (95% CI, 4.14 to 135.3) is truncated.